Company profile
Escalon Medical Corp.
OTC: ESMC · Healthcare · Medical - Devices
#612 of 1,418 Healthcare companies by revenue43rd-percentile growth
EA Score
——FH —DQ 53GM —SS 59
v0.1 · 25/100 weight · pillars only
↑ listing tenure, growth stability · ↓ filing timeliness, market scale
Methodology →Revenue TTM
$11.4M
Rev growth YoY (TTM)
-11.6%
Net income (FY)
$105.5k
Employees
39
as of 2026-09-23
Market cap
$1.4M
as of 2026-09-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$12.0M$12.0M2025
Net income$105.5k$105.5k2025
Operating income$133.2k$133.2k2025
Total assets$5.0M$5.0M2025
Liabilities$3.1M$3.1M2025
Equity$1.9M$1.9M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product96%
Service4%
By geography
Not disclosed.
The read
What is Escalon Medical Corp.’s revenue?
Escalon Medical Corp. booked $12.0M in FY2025 revenue, growing 0.5% year over year — about the middle of the pack among Healthcare companies we track, at a 0.9% net margin.
Peers · Healthcare
Elutia Inc52DDevonian Health Group Inc.46DPrelude Therapeutics Incorporated37DCYIOS Corporation49DBIMI International Medical Inc.——Cardiff Lexington Corporation51DNeighbors
Delaware →Key facts
CEORichard J. DePiano Jr.
SectorHealthcare
IndustryMedical - Devices
HeadquartersWayne, PA
ExchangeOTC: ESMC
Employees39
IPO date1992-09-11
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.